Early Heart Procedures Do Not Extend Life, Study Finds
Early Heart Procedures Do Not Extend Life, Study Finds
Early Heart Procedures Do Not Extend Life, Study Finds
Key points
اہم نکات
मुख्य बातें
- Patients with stable heart disease who have a stent or bypass operation early do not live longer than those treated first with medicines and lifestyle changes, a major long-term study has found.
- The ISCHEMIA-EXTEND follow-up tracked 5,179 patients at 320 hospitals in 37 countries, recording 1,071 deaths over up to 13 years.
- After nearly a decade, the chance of death was 26 percent in the early-procedure group and 27 percent in the group treated with medicines first.
- Patients with stable heart disease who have a stent or bypass operation early do not live longer than those treated first with medicines and lifestyle changes, a major long-term study has found.
- The ISCHEMIA-EXTEND follow-up tracked 5,179 patients at 320 hospitals in 37 countries, recording 1,071 deaths over up to 13 years.
- After nearly a decade, the chance of death was 26 percent in the early-procedure group and 27 percent in the group treated with medicines first.
- Patients with stable heart disease who have a stent or bypass operation early do not live longer than those treated first with medicines and lifestyle changes, a major long-term study has found.
- The ISCHEMIA-EXTEND follow-up tracked 5,179 patients at 320 hospitals in 37 countries, recording 1,071 deaths over up to 13 years.
- After nearly a decade, the chance of death was 26 percent in the early-procedure group and 27 percent in the group treated with medicines first.
Patients with stable heart disease who have a stent or bypass operation early do not live longer than those treated first with medicines and lifestyle changes, a major long-term study has found. The ISCHEMIA-EXTEND follow-up tracked 5,179 patients at 320 hospitals in 37 countries, recording 1,071 deaths over up to 13 years. After nearly a decade, the chance of death was 26 percent in the early-procedure group and 27 percent in the group treated with medicines first. The procedures did ease chest pain and improve quality of life, but they did not cut the overall death rate. The findings, presented at the American Heart Association meeting and published in JAMA, apply only to stable heart disease — stents and bypass remain lifesaving during a heart attack.
Patients with stable heart disease who have a stent or bypass operation early do not live longer than those treated first with medicines and lifestyle changes, a major long-term study has found. The ISCHEMIA-EXTEND follow-up tracked 5,179 patients at 320 hospitals in 37 countries, recording 1,071 deaths over up to 13 years. After nearly a decade, the chance of death was 26 percent in the early-procedure group and 27 percent in the group treated with medicines first. The procedures did ease chest pain and improve quality of life, but they did not cut the overall death rate. The findings, presented at the American Heart Association meeting and published in JAMA, apply only to stable heart disease — stents and bypass remain lifesaving during a heart attack.
Patients with stable heart disease who have a stent or bypass operation early do not live longer than those treated first with medicines and lifestyle changes, a major long-term study has found. The ISCHEMIA-EXTEND follow-up tracked 5,179 patients at 320 hospitals in 37 countries, recording 1,071 deaths over up to 13 years. After nearly a decade, the chance of death was 26 percent in the early-procedure group and 27 percent in the group treated with medicines first. The procedures did ease chest pain and improve quality of life, but they did not cut the overall death rate. The findings, presented at the American Heart Association meeting and published in JAMA, apply only to stable heart disease — stents and bypass remain lifesaving during a heart attack.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।